Representative before the EPO

Company dna brookes ip
no operation time available
857.5
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 17 EP applications Emma Jane Hodge has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 21, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13705581

FUSED DIHYDROPYRIDO [2,3 -B]PYRAZINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, C07D 471/04, A61P 11/00, A61P 9/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707437

FUSED PIPERIDINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PAH AND RELATED DISORDERS

IPC classification:
A61K 31/4985, C07D 471/04, A61P 11/00, A61P 9/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705582

FUSED PIPERIDINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, C07D 471/04, A61P 11/00, A61P 9/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707037

SALTS OF AN IP RECEPTOR AGONIST

IPC classification:
A61K 31/4985, C07D 471/04, A61P 11/00, A61P 9/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705579

7,8- DIHYDROPYRIDO [3, 4 - B]PYRAZINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, C07D 471/04, A61P 11/00, A61P 9/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705578

FUSED PYRROLES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, C07D 487/04, A61P 11/00, A61P 9/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13711952

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/4188, C07D 487/04, A61P 35/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13720079

CRYSTALLINE FORM OF A SUCCINATE SALT

IPC classification:
A61K 31/438, C07D 471/10, A61P 35/00, A61P 11/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13718037

PRODUCTION OF LIQUID HYDROCARBONS

IPC classification:
C10L 1/08, C10L 1/06, C10G 45/58, C10G 35/04
Agent:
Multiple attorneys, Brookes IP
Agent:
Richard Duncan Oldroyd, Brookes Batchellor LLP
Agent:
Multiple attorneys, Elkington and Fife LLP
Status:
The patent has been granted
EP16724452

TREATMENT OF FABRICS AND TEXTILES

IPC classification:
D06M 15/03, D06M 13/188
Agent:
Emma Jane Hodge, Brookes IP
Status:
Request for examination was made
EP16724102

CLEANING AND WASHING DOWN AND/OR FEATHERS

IPC classification:
B68G 3/10, D06L 1/12, D06M 15/03, D06M 19/00, C11D 11/00, C11D 3/20, C11D 1/66
Agent:
Emma Jane Hodge, Brookes IP
Status:
The patent has been granted
EP16729340

TRIAZINE DERIVATIVES AS INTERFERON-GAMMA INHIBITORS

IPC classification:
A61P 25/00, A61K 31/53
Applicant:
University of Greenwich
Agent:
Emma Jane Hodge, Brookes IP
Status:
Request for examination was made
EP16818810

SUBSTITUTED QUINAZOLINE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY

IPC classification:
A61P 25/16, A61P 25/28, A61K 31/553, A61K 31/506, A61K 31/505, A61K 31/519, C07D 495/04, C07D 239/94, C07D 403/04, C07D 405/14, C07D 409/04, C07D 405/12, C07D 413/14, C07D 471/04, C07D 401/14, C07D 401/04
Applicant:
Northwestern University
Agent:
Emma Jane Hodge, Brookes IP
Status:
Request for examination was made
EP16807983

BIPYRAMID-TEMPLATED SYNTHESIS OF MONODISPERSE NOBLE METAL NANOCRYSTALS

IPC classification:
B22F 9/24, B82Y 40/00, B82Y 20/00, C30B 7/00
Applicant:
University of Chicago
Agent:
Emma Jane Hodge, Brookes IP
Status:
Request for examination was made
EP16818813

SUBSTITUTED 4-METHYL-PYRROLO[1.2-A]PYRIMIDINE-8-CARBOXAMIDE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY

IPC classification:
A61P 25/16, A61P 25/28, A61K 31/519, C07D 519/00, C07D 487/04
Applicant:
Northwestern University
Agent:
Emma Jane Hodge, Brookes IP
Status:
Request for examination was made
EP16865255

UPTAKE OF PHARMACEUTICALS WITHIN CYCLODEXTRIN-BASED POROUS MATERIALS

IPC classification:
B01J 20/22, C08B 37/16
Applicant:
Northwestern University
Applicant:
King Abdulaziz City for Science and Technology (KACST)
Agent:
Emma Jane Hodge, Brookes IP
Status:
Request for examination was made
EP17700613

METHOD OF DYE CLEARING TEXTILES

IPC classification:
D06P 1/653, D06P 5/04, D06P 3/54
Agent:
Emma Jane Hodge, Brookes IP
Status:
The patent has been granted

Please Sign in to use this feature